{"id":4013,"date":"2026-01-29T01:06:07","date_gmt":"2026-01-29T01:06:07","guid":{"rendered":"https:\/\/bihavadis.com\/?p=4013"},"modified":"2026-01-29T01:06:07","modified_gmt":"2026-01-29T01:06:07","slug":"kanserden-daha-tehlikeli-hastalik-diyabetik-ayak","status":"publish","type":"post","link":"https:\/\/bihavadis.com\/index.php\/2026\/01\/29\/kanserden-daha-tehlikeli-hastalik-diyabetik-ayak\/","title":{"rendered":"Kanserden daha tehlikeli hastal\u0131k: Diyabetik ayak"},"content":{"rendered":"<p>Gazi \u00dcniversitesi T\u0131p Fak\u00fcltesi Kalp ve Damar Cerrahisi Uzman\u0131 Do\u00e7. Dr. Mustafa Hakan Zor, \u015feker hastalar\u0131nda g\u00f6r\u00fclen &#8216;diyabetik ayak&#8217; hastal\u0131\u011f\u0131 ve hastal\u0131\u011f\u0131n tedavisiyle ilgili a\u00e7\u0131klamada bulundu.<\/p>\n<p>Do\u00e7 Dr. Zor, bu hastal\u0131\u011fa zaman\u0131nda m\u00fcdahale edilmedi\u011finde hastan\u0131n ilk etapta aya\u011f\u0131n\u0131, daha sonra da hayat\u0131n\u0131 kaybetme riskiyle kar\u015f\u0131 kar\u015f\u0131ya kald\u0131\u011f\u0131n\u0131 s\u00f6yledi. \u015eeker hastalar\u0131n\u0131n ayaklar\u0131nda a\u00e7\u0131lan ve yakla\u015f\u0131k 3 ay kapanmayan yaralar\u0131 &#8216;diyabetik ayak&#8217; hastal\u0131\u011f\u0131 olarak tan\u0131mlad\u0131klar\u0131n\u0131 belirten ve bu hastal\u0131\u011f\u0131n \u00f6l\u00fcm riskine dikkat \u00e7eken Do\u00e7 Dr. Zor, \u015f\u00f6yle konu\u015ftu:<\/p>\n<p><strong>&#8220;Diyabetik ayak hastal\u0131\u011f\u0131 kanserden daha tehlikeli bir hastal\u0131k. Diyabetik ayak hastalar\u0131nda bu ilac\u0131 kullan\u0131yoruz; \u00e7\u00fcnk\u00fc diyabetik ayak, kanser gibi bir hastal\u0131k hatta 5 y\u0131ll\u0131k ya\u015fam oran\u0131 kanserden daha d\u00fc\u015f\u00fck. Kanserli bir hastada 5 y\u0131ll\u0131k ya\u015fam oran\u0131 y\u00fczde 40 ila 50 civar\u0131nda bulunuyor; ancak diyabetik ayak hastal\u0131\u011f\u0131 sebebiyle aya\u011f\u0131 kesilen bir hastan\u0131n 5 y\u0131ll\u0131k ya\u015fam oran\u0131 y\u00fczde 30&#8217;lara d\u00fc\u015f\u00fcyor. Bu hastalar\u0131n yakla\u015f\u0131k y\u00fczde 50&#8217;sinin bacaklar\u0131nda \u00f6zellikle diz alt\u0131nda, damar problemi var. Hastalar bize &#8216;kritik bacak istemisi&#8217; dedi\u011fimiz kapanmayan yaralar ya da kangren \u015fikayetiyle geliyorlar. \u0130lk tan\u0131 konulduktan sonra, bu hastalar\u0131n yakla\u015f\u0131k y\u00fczde 20&#8217;si herhangi bir m\u00fcdahale yap\u0131lmadan ilk 6 ay i\u00e7inde kaybediliyor. Y\u00fczde 40&#8217;l\u0131k k\u0131sm\u0131n\u0131n baca\u011f\u0131 diz alt\u0131ndan ya da diz \u00fczerinden kesilip ya\u015fam\u0131na devam ederken di\u011fer y\u00fczde 40&#8217;l\u0131k k\u0131s\u0131m ise aya\u011f\u0131 kesilmeden; ama s\u0131k\u0131nt\u0131lar\u0131 devam ederek ya\u015fant\u0131lar\u0131na devam ediyorlar.&#8221;<\/strong><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/bihavadis.com\/wp-content\/uploads\/2026\/01\/kanserden-daha-tehlikeli-hastalik-diyabetik-ayak-0-bmQBt9DU.jpg\"><\/p>\n<p><b>K\u00dcBA&#8217;DAN GELEN \u0130LA\u00c7LA TEDAV\u0130 ED\u0130L\u0130YOR<\/b><\/p>\n<p>\u00d6l\u00fcm riski ta\u015f\u0131yan bu yaralar\u0131 K\u00fcba&#8217;dan gelen bir ila\u00e7la tedavi ettiklerini ifade eden Do\u00e7. Dr. Zor, <strong>&#8220;Biz bu yaralar\u0131 bir tak\u0131m kanland\u0131rma i\u015flemleri, ameliyatlar ya da anjiyo plasti ile a\u00e7t\u0131ktan sonra K\u00fcba&#8217;dan ithal edilen ila\u00e7lar\u0131 kullanarak, hastalar\u0131n yara kapanmas\u0131n\u0131 h\u0131zland\u0131r\u0131p, bu s\u00fcreyi azalt\u0131yoruz. Do\u011fru end\u00fckasyonda kullan\u0131ld\u0131\u011f\u0131 zaman hastalar\u0131n yaras\u0131n\u0131 daha h\u0131zl\u0131 ve g\u00fcvenli bir \u015fekilde kapat\u0131yor&#8221; <\/strong>dedi.<\/p>\n<div>\n<div>  <\/div>\n<\/div>\n<p><img decoding=\"async\" src=\"https:\/\/bihavadis.com\/wp-content\/uploads\/2026\/01\/kanserden-daha-tehlikeli-hastalik-diyabetik-ayak-1-qzBnh42n.jpg\"\/><\/p>\n<p><b>&#8220;\u00dcLKEM\u0130ZDE \u00dcRET\u0130L\u0130RSE MAL\u0130YET D\u00dc\u015eER&#8221;<\/b><\/p>\n<p>Ancak K\u00fcba&#8217;dan gelen bu ila\u00e7lar\u0131n y\u00fcksek maliyetli oldu\u011funu anlatan Zor, <strong>&#8220;Biz kullanmaya ba\u015flad\u0131\u011f\u0131m\u0131z d\u00f6nemde 1100 dolar civar\u0131 maliyetleri vard\u0131. Bu ila\u00e7 1990\u2019l\u0131 y\u0131llar\u0131n ortalar\u0131nda Havana\u2019da \u00fcretildi. \u00dclkemize de 2012 y\u0131l\u0131nda getirildi ve biz 2013 y\u0131l\u0131nda bu ilac\u0131 uygulamaya ba\u015flad\u0131k. \u00dclkemizde \u00fcretilmesi durumunda maliyetler d\u00fc\u015fecektir. \u0130laca ula\u015f\u0131m kolayla\u015facakt\u0131r. Hem hastalar\u0131n hem de devletin faydas\u0131na olacakt\u0131r. \u0130la\u00e7, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan diyabetik ayak hastalar\u0131nda tek bir end\u00fckasyonda kullan\u0131l\u0131yor. Belki T\u00fcrkiye\u2019de \u00fcretildikten sonra daha geni\u015f end\u00fckasyon alanlar\u0131nda kullan\u0131labilir&#8221; <\/strong>dedi.<\/p>\n<p>\u0130la\u00e7 do\u011fru kullan\u0131ld\u0131\u011f\u0131nda hastalara ve devlete olan y\u00fck\u00fcn azalaca\u011f\u0131n\u0131 ifade eden Zor, <strong>&#8220;Yurt d\u0131\u015f\u0131nda yap\u0131lan bir \u00e7al\u0131\u015fmada bu hastalar\u0131n y\u0131ll\u0131k maliyetleri 20 bin dolar ile 100 bin dolar aras\u0131nda de\u011fi\u015fiyor. Yani ilac\u0131 pahal\u0131 kullan\u0131yoruz ama do\u011fru hastalarda do\u011fru \u015fekilde kullan\u0131ld\u0131\u011f\u0131 zaman hastalar\u0131n devlete olan y\u00fck\u00fcn\u00fc de azaltabilecek&#8221;<\/strong> diye konu\u015ftu. <\/p>\n<p><img decoding=\"async\" src=\"https:\/\/bihavadis.com\/wp-content\/uploads\/2026\/01\/kanserden-daha-tehlikeli-hastalik-diyabetik-ayak-2-OPxRqy9V.jpg\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kanserli bir hastada 5 y\u0131ll\u0131k ya\u015fam oran\u0131 y\u00fczde 40 ila 50 civar\u0131nda iken, &#8216;diyabetik ayak&#8217; nedeniyle aya\u011f\u0131 kesilen bir hastan\u0131n 5 y\u0131ll\u0131k ya\u015fam oran\u0131 y\u00fczde 30&#8217;lara d\u00fc\u015f\u00fcyor.<\/p>\n","protected":false},"author":1,"featured_media":4014,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[702,660,704,703,678],"class_list":["post-4013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-ayak","tag-ilac","tag-maliyet","tag-yara","tag-yuzde"],"_links":{"self":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/4013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/comments?post=4013"}],"version-history":[{"count":1,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/4013\/revisions"}],"predecessor-version":[{"id":4018,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/4013\/revisions\/4018"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media\/4014"}],"wp:attachment":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media?parent=4013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/categories?post=4013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/tags?post=4013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}